Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men

Journal of Experimental Medicine

Volumn 203, Issue 12, 2006, Pages 2627-2638

  Bogunovic, Milena ^a   Ginhoux, Florent ^a   Wagers, Amy ^b   Loubeau, Martine ^a   Isola, Luis M ^a   Lubrano, Lauren ^a   Najfeld, Vesna ^a   Phelps, Robert G ^a   Grosskreutz, Celia ^a   Scigliano, Eilleen ^a   Frenette, Paul S ^a   Merad, Miriam ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CHIMERA; CONGENIC ANIMAL; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; GRAFT VERSUS HOST REACTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN CELL; STEADY STATE;

ACUTE DISEASE; ANIMALS; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; ORGAN SPECIFICITY; RADIATION CHIMERA; SKIN;

EID: 33751526996     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20060667     Document Type: Article

References (68)

1. Valladeau, J., and S. Saeland. 2005. Cutaneous dendritic cells. Semin. Immunol. 17:273-283.
2. Schuler, G., F. Koch, C. Heufler, E. Kampgen, G. Topar, and N. Romani. 1993. Murine epidermal Langerhans cells as a model to study tissue dendritic cells. Adv. Exp. Med. Biol. 329:243-249.
3. Cerio, R., C.E. Griffiths, K.D. Cooper, B.J. Nickoloff, and J.T. Headington. 1989. Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skin. Br. J. Dermatol. 121:421-431.
4. Nestle, F.O., L.A. Turka, and B.J. Nickoloff. 1994. Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines. J. Clin. Invest. 94:202-209.
5. Lenz, A., M. Heine, G. Schuler, and N. Romani. 1993. Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization. J. Clin. Invest. 92:2587-2596.
6. Duraiswamy, N., Y. Tse, C. Hammerberg, S. Kang, and K.D. Cooper. 1994. Distinction of class II MHC+ Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages. J. Invest. Dermatol. 103:678-683.
7. Dupasquier, M., P. Stoitzner, A. van Oudenaren, N. Romani, and P.J. Leenen. 2004. Macrophages and dendritic cells constitute a major subpopulation of cells in the mouse dermis. J. Invest. Dermatol. 123:876-879.
8. Ebner, S., Z. Ehammer, S. Holzmann, P. Schwingshackl, M. Forstner, P. Stoitzner, G.M. Huemer, P. Fritsch, and N. Romani. 2004. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int. Immunol. 16:877-887.
9. Valladeau, J., O. Ravel, C. Dezutter-Dambuyant, K. Moore, M. Kleijmeer, Y. Liu, V. Duvert-Frances, C. Vincent, D. Schmitt, J. Davoust, et al. 2000. Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity. 12:71-81.
10. Pope, M., M.G. Betjes, H. Hirmand, L. Hoffman, and R.M. Steinman. 1995. Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates. J. Invest. Dermatol. 104:11-17.
11. Williams, I.R., and T.S. Kupper. 1996. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci. 58:1485-1507.
12. Bennett, C.L., E. van Rijn, S. Jung, K. Inaba, R.M. Steinman, M.L. Kapsenberg, and B.E. Clausen. 2005. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169:569-576.
13. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhe, P. Perrin, N. Romani, C.H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 22:643-654.
14. Sreilein, J.W. 1989. Antigen-presenting cells in the induction of contact hypersentivity in mice: evidence that Langerhans cells are sufficient but not required. J. Invest. Dermatol. 93:443-448.
15. Kaplan, D.H., M.C. Jenison, S. Saeland, W.D. Shlomchik, and M.J. Shlomchik. 2005. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity. 23:611-620.
16. Fossum, S. 1989. The life history of dendritic leukocytes (DL). Curr. Top. Pathol. 79:101-124.
17. Katz, S.I., K. Tamaki, and D.H. Sachs. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature. 282:324-326.
18. Holt, P.G., S. Haining, D.J. Nelson, and J.D. Sedgwick. 1994. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J. Immunol. 153:256-261.
19. Merad, M., M.G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I.L. Weissman, J.G. Cyster, and E.G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3:1135-1141.
20. Shlomchik, W.D., M.S. Couzens, C.B. Tang, J. McNiff, M.E. Robert, J. Liu, M.J. Shlomchik, and S.G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 285:412-415.
21. Zhang, Y., J.P. Louboutin, J. Zhu, A.J. Rivera, and S.G. Emerson. 2002. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109:1335-1344.
22. Zhang, Y., W.D. Shlomchik, G. Joe, J.P. Louboutin, J. Zhu, A. Rivera, D. Giannola, and S. Emerson. 2002. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J. Immunol. 169:7111-7118.
23. Chan, G.W., G. Gorgun, K.B. Miller, and F.M. Foss. 2003. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol. Blood Marrow Transplant. 9:170-176.
24. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M.G. Manz, S.A. Lira, I. Charo, D.N. Cook, I.L. Weissman, S. Strober, and E.G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10:510-517.
25. Duffner, U.A., Y. Maeda, K.R. Cooke, P. Reddy, R. Ordemann, C. Liu, J.L. Ferrara, and T. Teshima. 2004. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J. Immunol. 172:7393-7398.
26. Anderson, B.E., J.M. McNiff, D. Jain, B.R. Blazar, W.D. Shlomchik, and M.J. Shlomchik. 2005. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood. 105:2227-2234.
27. Vogelsang, G.B., L. Lee, and D.M. Bensen-Kennedy. 2003. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu. Rev. Med. 54:29-52.
28. Figdor, C.G. 2003. Molecular characterization of dendritic cells operating at the interface of innate or acquired immunity. Pathol. Biol. (Paris). 51:61-63.
29. Scholzen, T., and J. Gerdes. 2000. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182:311-322.
30. Gerdes, J., H. Lemke, H. Baisch, H.H. Wacker, U. Schwab, and H. Stein. 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1710-1715.
31. Gerdes, J., L. Li, C. Schlueter, M. Duchrow, C. Wohlenberg, C. Gerlach, I. Stahmer, S. Kloth, E. Brandt, and H.D. Flad. 1991. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138:867-873.
32. Sebastiani, S., C. Albanesi, P.O. De, P. Puddu, A. Cavani, and G. Girolomoni. 2002. The role of chemokines in allergic contact dermatitis. Arch. Dermatol. Res. 293:552-559.
33. Barker, J.N., M.L. Jones, C.L. Swenson, V. Sarma, R.S. Mitra, P.A. Ward, K.J. Johnson, J.C. Fantone, V.M. Dixit, and B.J. Nickoloff. 1991. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-gamma. J. Immunol. 146:1192-1197.
34. Campbell, J.J., G. Haraldsen, J. Pan, J. Rottman, S. Qin, P. Ponath, D.P. Andrew, R. Warnke, N. Ruffing, N. Kassam, et al. 1999. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 400:776-780.
35. Katou, F., H. Ohtani, T. Nakayama, K. Ono, K. Matsushima, A. Saaristo, H. Nagura, O. Yoshie, and K. Motegi. 2001. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue. Am. J. Pathol. 158:1263-1270.
36. Tensen, C.P., J. Flier, E.M. Van Der Raaij-Helmer, S. Sampat-Sardjoepersad, R.C. Van Der Schors, R. Leurs, R.J. Scheper, D.M. Boorsma, and R. Willemze. 1999. Human IP-9: a keratinocytederived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J. Invest. Dermatol. 112:716-722.
37. Flier, J., D.M. Boorsma, P.J. van Beek, C. Nieboer, T.J. Stoof, R. Willemze, and C.P. Tensen. 2001. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J. Pathol. 194:398-405.
38. Dieu-Nosjean, M.C., C. Massacrier, B. Homey, B. Vanbervliet, J.J. Pin, A. Vicari, S. Lebecque, C. Dezutter-Dambuyant, D. Schmitt, A. Zlotnik, and C. Caux. 2000. Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J. Exp. Med. 192:705-718.
39. Nakayama, T., R. Fujisawa, H. Yamada, T. Horikawa, H. Kawasaki, K. Hieshima, D. Izawa, S. Fujiie, T. Tezuka, and O. Yoshie. 2001. Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis. Int. Immunol. 13:95-103.
40. Pablos, J.L., A. Amara, A. Bouloc, B. Santiago, A. Caruz, M. Galindo, T. Delaunay, J.L. Virelizier, and F. Arenzana-Seisdedos. 1999. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am. J. Pathol. 155:1577-1586.
41. Morales, J., B. Homey, A.P. Vicari, S. Hudak, E. Oldham, J. Hedrick, R. Orozco, N.G. Copeland, N.A. Jenkins, L.M. McEvoy, and A. Zlotnik. 1999. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc. Natl. Acad. Sci. USA. 96:14470-14475.
42. Schaerli, P., K. Willimann, L.M. Ebert, A. Walz, and B. Moser. 2005. Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity. 23:331-342.
43. Serbina, N.V., and E.G.P. Am. 2006. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7:311-317.
44. Merad, M., T. Sugie, E.G. Engleman, and L. Fong. 2002. In vivo manipulation of dendritic cells to induce therapeutic immunity. Blood. 99:1676-1682.
45. Grosskreutz, C., V. Ross, E. Scigliano, S. Fruchtman, and L. Isola. 2003. Low-dose total body irradiation, fludarabine, and antithymocyte globulin conditioning for nonmyeloablative allogeneic transplantation. Biol. Blood Marrow Transplant. 9:453-459.
46. Kabashima, K., T.A. Banks, K.M. Ansel, T.T. Lu, C.F. Ware, and J.G. Cyster. 2005. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity. 22:439-450.
47. Lyman, S.D., and S.E. Jacobsen. 1998. c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 91:1101-1134.
48. Shizuru, J.A., R.S. Negrin, and I.L. Weissman. 2005. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu. Rev. Med. 56:509-538.
49. Ikuta, K., N. Uchida, J. Friedman, and I.L. Weissman. 1992. Lymphocyte development from stem cells. Annu. Rev. Immunol. 10:759-783.
50. Kamath, A.T., J. Pooley, M.A. O'Keeffe, D. Vremec, Y. Zhan, A.M. Lew, A. D'Amico, L. Wu, D.F. Tough, and K. Shortman. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165:6762-6770.
51. Kamath, A.T., S. Henri, F. Battye, D.F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood. 100:1734-1741.
52. Ginhoux, F., F. Tacke, V. Angeli, M. Bogunovic, X.M. Dai, E. Stanley, G.J. Randolph, and M. Merad. 2006. Langerhans cells arise from monocytes in vivo. Nat. Immunol. 7:265-273.
53. Mielcarek, M., and R. Storb. 2003. Non-myeloablative hematopoietic cell transplantation as immunotherapy for hematologic malignancies. Cancer Treat. Rev. 29:283-290.
54. Collin, M.P., D.N. Hart, G.H. Jackson, G. Cook, J. Cavet, S. Mackinnon, P.G. Middleton, and A.M. Dickinson. 2006. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J. Exp. Med. 203:27-33.
55. Mielcarek, M., and R. Storb. 2005. Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation. Leuk. Lymphoma. 46:1251-1260.
56. Mielcarek, M., P.J. Martin, W. Leisenring, M.E. Flowers, D.G. Maloney, B.M. Sandmaier, M.B. Maris, and R. Storb. 2003. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 102:756-762.
57. Peggs, K.S., K. Thomson, D.P. Hart, J. Geary, E.C. Morris, K. Yong, A.H. Goldstone, D.C. Linch, and S. Mackinnon. 2004. Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. Blood. 103:1548-1556.
58. Marks, D.I., R. Lush, J. Cavenagh, D.W. Milligan, S. Schey, A. Parker, F.J. Clark, L. Hunt, J. Yin, S. Fuller, et al. 2002. The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. Blood. 100:3108-3114.
59. Ferrara, J.L., and H.J. Deeg. 1991. Graft-versus-host disease. N. Engl. J. Med. 324:667-674.
60. Mapara, M.Y., Y.M. Kim, S.P. Wang, R. Bronson, D.H. Sachs, and M. Sykes. 2002. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood. 100:1903-1909.
61. Vogelsang, G.B., D. Wolff, V. Altomonte, E. Farmer, W.L. Morison, R. Corio, and T. Horn. 1996. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplant. 17:1061-1067.
62. Braverman, I.M., S. Klein, and A. Grant. 1987. Electron microscopic and immunolabeling studies of the lesional and normal skin of patients with mycosis fungoides treated by total body electron beam irradiation. J. Am. Acad. Dermatol. 16:61-74.
63. McGregor, D.H., Q. Yang, F. Fan, R.L. Talley, and M. Topalovski. 2001. Scabies associated with radiation therapy for cutaneous T-cell lymphoma. Ann. Clin. Lab. Sci. 31:103-107.
64. Boring, L., J. Gosling, S.W. Chensue, S.L. Kunkel, R.V. Farese Jr., H.E. Broxmeyer, and I.F. Charo. 1997. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J. Clin. Invest. 100:2552-2561.
65. Cook, D.N., D.M. Prosser, R. Forster, J. Zhang, N.A. Kuklin, S.J. Abbondanzo, X.D. Niu, S.C. Chen, D.J. Manfra, M.T. Wiekowski, et al. 2000. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity. 12:495-503.
66. Lindquist, R.L., G. Shakhar, D. Dudziak, H. Wardemann, T. Eisenreich, M.L. Dustin, and M.C. Nussenzweig. 2004. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5:1243-1250.
67. Wright, D.E., A.J. Wagers, A.P. Gulati, F.L. Johnson, and I.L. Weissman. 2001. Physiological migration of hematopoietic stem and progenitor cells. Science. 294:1933-1936.
68. Najfeld, V., W. Burnett, A. Vlachos, E. Scigliano, L. Isola, and S. Fruchtman. 1997. Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant. 19:829-834.